Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
25%
OVERLAP
BY WEIGHT
18
# OF OVERLAPPING
HOLDINGS
FBT
31
HOLDINGS
60%
ALSO IN WDNA
WDNA
85
HOLDINGS
21%
ALSO IN FBT
SECTOR DRIFT (FBT minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
| NATERA INC | 4.0% | 4.4% | 4.0% | |
| ALNYLAM PHARMACEUTICALS INC | 2.8% | 3.0% | 2.8% | |
| UNITED THERAPEUTICS CORP | 3.1% | 2.2% | 2.2% | |
| VERACYTE INC | 3.9% | 2.1% | 2.1% | |
| GILEAD SCIENCES INC | 3.0% | 1.9% | 1.9% | |
FBT Overweight Relative to WDNA
| BRUKER CORP | 3.9% | |
| EXACT SCIENCES CORP | 3.8% | |
| ACADIA PHARMACEUTICALS INC | 3.5% | |
| INCYTE CORP | 3.5% | |
| WATERS CORP | 3.5% | |
| KRYSTAL BIOTECH, INC. | 3.4% | |
| METTLER-TOLEDO INTERNATIONAL | 3.3% | |
| EXELIXIS INC | 3.3% | |
| HALOZYME THERAPEUTICS INC | 3.2% | |
| NEUROCRINE BIOSCIENCES INC | 3.2% |
FBT Underweight Relative to WDNA
| BRIDGEBIO PHARMA, INC. | -4.0% | |
| BLUEPRINT MEDICINES CORP. | -3.8% | |
| NOVOZYMES A/S-B SHARES | -3.2% | |
| STOKE THERAPEUTICS, INC. | -2.3% | |
| ELI LILLY & CO | -2.3% | |
| TWIST BIOSCIENCE CORP. | -2.2% | |
| AGIOS PHARMACEUTICALS INC | -2.1% | |
| IONIS PHARMACEUTICALS, INC. | -2.1% | |
| NOVARTIS AG | -1.9% | |
| VERICEL CORPORATION | -1.8% |